Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$278.73 - $327.27 $705,186 - $827,993
-2,530 Closed
0 $0
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $435,349 - $541,029
-1,855 Reduced 42.3%
2,530 $725,000
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $985,967 - $1.22 Million
4,385 New
4,385 $1.21 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Cs Group, LLC Portfolio

Follow Capital Cs Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Cs Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Cs Group, LLC with notifications on news.